Listed

Amphastar Pharmaceuticals, Inc.

AMPHNasdaqCIK 1297184HealthcareFiscal year ends Dec 31

Reports and events: 172 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Amphastar Pharmaceuticals, Inc., Reports and events
FiledFormWhat it isAccession number
2016-03-1416:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-16-004110
2015-11-1306:07 ET10-QQuarterly reportPeriod 2015-09-300001558370-15-002652
2015-11-1216:12 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-15-002630
2015-08-1316:00 ET10-QQuarterly reportPeriod 2015-06-300001171843-15-004674
2015-08-1216:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-15-004597
2015-06-2206:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-003533
2015-06-0117:55 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001104659-15-042113
2015-05-1406:00 ET10-QQuarterly reportPeriod 2015-03-310001171843-15-002835
2015-05-1306:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-15-002788
2015-04-0816:00 ETDEF 14AProxy statementPeriod 2015-05-270001171843-15-001880
2015-03-2606:10 ET10-KAnnual reportPeriod 2014-12-310001171843-15-001654
2015-03-2416:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-15-001600
2014-11-1316:19 ET10-QQuarterly reportPeriod 2014-09-300001171843-14-005537
2014-11-1216:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-14-005466
2014-08-1316:17 ET10-QQuarterly reportPeriod 2014-06-300001171843-14-003951
2014-08-1216:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-14-003915
2014-08-0620:32 ET8-K1.01 Entry into a material agreement0001104659-14-057093
2014-07-0116:29 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001104659-14-049724
2014-06-1815:12 ETS-1/ARegistration statement, amended0001047469-14-005704
2014-06-1321:56 ETS-1/ARegistration statement, amended0001047469-14-005558
2014-06-0517:21 ETS-1/ARegistration statement, amended0001047469-14-005387
2014-05-2021:42 ETS-1Registration statement0001047469-14-005043

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 17:01 ET. Listed shows no prices and gives no investment advice.